BIVV003 (darpagliflozin)

BIVV003, also known as darpagliflozin, is an experimental medication designed to help control blood sugar levels in people with type 2 diabetes. It works by blocking a specific protein in your kidneys, which reduces how much sugar gets reabsorbed into your blood from urine. Instead, more sugar is expelled through urine, helping lower blood sugar levels. This approach can be used alongside other diabetes treatments. As an investigational drug, darpagliflozin is still being studied to determine its safety and effectiveness.